Abstract:Previous studies suggest associations between self-reported sleep problems and poorer health, cognition, Alzheimer's disease pathology and dementia-related outcomes. It is important to develop a deeper understanding of the relationship between these complications and sleep disturbance, a modifiable risk factor, in late midlife, a time when Alzheimer's disease pathology may be accruing. The objectives of this study included application of unsupervised machine learning procedures to identify distinct subgroups of persons with problematic sleep and the association of these subgroups with concurrent measures of mental and physical health, cognition and PET-identified amyloid. Dementia-free participants from the Wisconsin Registry for Alzheimer's Prevention (n = 619) completed sleep questionnaires including the Insomnia Severity Index, Epworth Sleepiness Scale and Medical Outcomes Study Sleep Scale. K-means clustering analysis identified discrete sleep problem groups who were then compared across concurrent health outcomes (e.g. depression, self-rated health and insulin resistance), cognitive composite indices including episodic memory and executive function and, in a subset, Pittsburgh Compound B PET imaging to assess amyloid burden. Significant omnibus tests (P < 0.05) were followed with pairwise comparisons. Mean (SD) sample baseline sleep assessment age was 62.6 (6.7). Cluster analysis identified three groups: healthy sleepers [n = 262 (42.3%)], intermediate sleepers [n = 229 (37.0%)] and poor sleepers [n = 128 (20.7%)]. All omnibus tests comparing demographics and health measures across sleep groups were significant except for age, sex and apolipoprotein E e4 carriers; the poor sleepers group was worse than one or both of the other groups on all other measures, including measures of depression, self-reported health and memory complaints. The poor sleepers group had higher average body mass index, waist-hip ratio and homeostatic model assessment of insulin resistance. After adjusting for covariates, the poor sleepers group also performed worse on all concurrent cognitive composites except working memory. There were no differences between sleep groups on PET-based measures of amyloid. Sensitivity analyses indicated that while different clustering approaches resulted in different group assignments for some (predominantly the intermediate group), between-group patterns in outcomes were consistent. In conclusion, distinct sleep characteristics groups were identified with a sizable minority (20.7%) exhibiting poor sleep characteristics, and this group also exhibited the poorest concurrent mental and physical health and cognition, indicating substantial multi-morbidity; sleep group was not associated with amyloid PET estimates. Precision-based management of sleep and related factors may provide an opportunity for early intervention that could serve to delay or prevent clinical impairment.

Sleep and APOE‐ε4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults

Regulating Effect of CBF on Memory in Cognitively Normal Older Adults with Different ApoE Genotype: the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Associations Between APOE Genotype and Cerebral Small-Vessel Disease: a Longitudinal Study

Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity

Apolipoprotein E polymorphism ε4‐stratified longitudinal association between daytime naps, sleep apnea and mild cognitive impairment: A prospective cohort study

APOEε4 and slow wave sleep in older adults

DECREASED INTRINSIC FUNCTIONAL NETWORK IN COGNITIVELY INTACT ELDERLY APOE-E4 CARRIERS MEASURED BY EIGENVECTOR CENTRALITY MAPPING

IC-P-060: Decreased Intrinsic Functional Network in Cognitively Intact Elderly APOE-E4 Carriers Measured by Eigenvector Centrality Mapping

Correlation Between the APOE Ε4 Genotype, Lifestyle Habits, and Cognitive Deficits in Chinese Adults over 60: a Cross-Sectional Analysis in China

Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease

Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia

Plasma neurofilament light chain in cognitively unimpaired late middle‐aged & older adult <i>APOE ε4</i> homozygotes, heterozygotes, & non‐carriers from the Arizona APOE Cohort

Association of objective sleep duration with cognition and brain aging biomarkers in older adults

Reduced rapid eye movement sleep in late middle-aged and older apolipoprotein E ɛ 4 allele carriers

Sleep Disturbance is Associated with Mild Cognitive Impairment: a Community Population-Based Cross-Sectional Study

1030 APOE Genotype and Sleep Architecture

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's Prevention

The Association of Subjective Sleep Characteristics and Plasma Biomarkers of Alzheimer's Disease Pathology in Older Cognitively Unimpaired Adults with Higher Amyloid-Β Burden.

APOE Ε4 Allele Accelerates Age-Related Multi-Cognitive Decline and White Matter Damage in Non-Demented Elderly.

Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults

Neutrophil Activation May Trigger Tau Burden Contributing to Cognitive Progression of Chronic Sleep Disturbance in Elderly Individuals Not Living with Dementia